In Vitro and in Silico Characterization of Lemborexant (E2006), a Novel Dual Orexin Receptor Antagonist

Journal of Pharmacology and Experimental Therapeutics- United States

doi 10.1124/jpet.117.241422

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Inhibition of Ghrelin-Induced Feeding in Rats by Pretreatment With a Novel Dual Orexin Receptor Antagonist

Journal of Physiological Sciences
Physiology
2017English

In Silico Identification of Novel Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes Mellitus

Enzyme Engineering
2015English

In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1997English

In Vitro Pharmacological Characterization of a Novel TRPA1 Antagonist and Proof of Mechanism in a Human Dental Pulp Model

Journal of Pain Research
AnesthesiologyPain Medicine
2013English

A Selective Orexin-1 Receptor Antagonist, SB334867, Blocks 2-Dg-Induced Gastric Acid Secretion in Rats

Neuroscience Letters
Neuroscience
2005English

Neuropeptide Y-Induced Orexigenic Action Is Attenuated by the Orexin Receptor Antagonist in Bullfrog Larvae

Frontiers in Neuroscience
Neuroscience
2017English

Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor 1 and Thromboxane A2 Receptor, on Sephadex-Induced Airway Inflammation in Rats

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Pharmacological Characterization of Cinnamophilin, a Novel Dual Inhibitor of Thromboxane Synthase and Thromboxane A2 Receptor

British Journal of Pharmacology
Pharmacology
1994English

In Silico Design and in Vitro Characterization of Universal Tyrosine Kinase Peptide Substrates

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy